Skip to main content
. 2021 Jan 9;296:100251. doi: 10.1074/jbc.RA120.016573

Table 1.

Kinetics of PARP1 inhibitor binding to PARP1 and TNKS1a,b

Inhibitor PARP1
TNKS1
kon (M−1 s−1) koff (s−1) t1/2 (min) Kin. KD (nM) kon (M−1 s−1) koff (s−1) t1/2 (min) Kin. KD (nM)
Talazoparib 1.3 × 105 7.3 × 10−5 158 0.6 ± 0.1 1.8 × 105 2.6 × 10−3 4 14 ± 1
Olaparib 1.1 × 105 8.8 × 10−5 131 0.8 ± 0.1 1.1 × 105 1.7 × 10−1 0.1 1700 ± 6
Veliparib 7.5 × 105 3.6 × 10−3 5 6.2 ± 3.5 3.1 × 103 5.4 × 10−2 0.2 17,500 ± 300
Niraparib 3.4 × 105 1.7 × 10−3 7 5.4 ± 1.4 2.5 × 104 8.3 × 10−1 0.01 34,800 ± 540
a

Binding kinetics measured in 25 mM Hepes, 150 mM NaCl, 5% glycerol, 0.5 mM TCEP, 2% DMSO, 0.02% Tween 20, and pH 7.4, at 25 °C.

b

Each value in the table represents an average of two or more independent measurements.